Best of Hematology & Breast Cancer™ 2027, Seattle
Accreditation: 6.75 AMA PRA Category 1 Credit™ | 6.75 ABIM MOC II | 6.75 Nursing Contact Hours | 6.75 ACPE Pharmacy
Venue: Seattle Marriott Waterfront, 2100 Alaskan Way, Seattle, WA, 98121, United States
Official conference page for Best of Hematology & Breast Cancer™ 2027, Seattle. https://binaytara.org/projects/conferences/best-of-hematology-breast-cancer-2027-seattle
About Best of Hematology & Breast Cancer™ 2027, Seattle


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, January 30th, 2027
All timings are in Pacific Time (PST, GMT-08:00) time.
Session Chair: David Aboulafia, MD
08:20 AM - 08:40 AM
AML/MDS – Bart L Scott, MD
08:40 AM - 08:50 AM
Q&A
08:50 AM - 09:10 AM
ALL – Ryan Cassaday, MD
09:10 AM - 09:20 AM
Q&A
09:20 AM - 09:40 AM
MPN/CML – Vivian G Oehler, MD
09:40 AM - 09:50 AM
Q&A
09:50 AM - 10:05 AM
Importance of Lifestyle Factors in Breast Cancer Care (Update from SABCS) – Natasha Kwendakwema, MD
10:05 AM - 10:20 AM
Panel Discussion
Moderator:
Fengting Yan, MD
Panelist:
Marko Velimirovic, MD
Session Chair: Prakash Vishnu, MD
10:30 AM - 10:50 AM
CLL
10:50 AM - 11:00 AM
Q&A
11:00 AM - 11:20 AM
Lymphoma Updates – Mengyang Di, MD, PhD
11:20 AM - 11:30 AM
Q&A
Session Chair: Fengting Yan, MD
11:30 AM - 11:45 AM
Who Really Needs More Adjuvant Therapy? – Brie Chun, MD
11:45 AM - 12:00 PM
Radiation: Doing Less Without Compromising Cure – L. Christine Fang, MD
12:00 PM - 12:15 PM
Surgery: Doing Less Without Compromising Cure – Emily N Palmquist, MD
12:15 PM - 12:30 PM
Case-Based Panel Discussion | Triple Negative Breast Cancer Local Recurrence
01:30 PM - 01:50 PM
Updates in Myeloma – Rahul Banerjee, MD
01:50 PM - 02:15 PM
Case-Based Discussion
Session Chair: Hannah Linden, MD
02:15 PM - 02:30 PM
What's Next After CDK4/6? ER+/HER2- Metastatic Breast Cancer – Hannah Linden, MD
02:30 PM - 02:45 PM
Are We Finally Winning in Triple-Negative Breast Cancer? – Lynn Symonds, MD
02:45 PM - 03:00 PM
Less May Be More: De-Escalation in HER2+ Disease
03:00 PM - 03:15 PM
Case-Based Panel Discussion | A Metastatic Breast Cancer Case, ER+, HER2- – Xiaowen Wang, MD
